Invested in Sustainable Value Creation

Wavelength’s Operating Executives specialize in the
nexus of Lifesciences, Healthcare, and Technology.

We focus on delivering sustainable value...
not on account development.

Expertise Bound With Long Term Perspective

Wavelength’s Operating Executives specialize in the nexus of Lifesciences, Healthcare, and Technology. We deliver transformations resulting in sustainable business value.

We solve complex problems with small teams possessing deep industry expertise. Rolling up our sleeves, we get our hands dirty and work quickly to distill and resolve your needs - driven by an energy and passion for great results. You can count on us to introduce fresh, sound ideas tempered by an experience-tested dose of realism. We always align with our business partners through shared interests.

Our approach will be most refreshing if you’ve ever been oversupplied with high dollar, marginal talent, sold work that didn’t move the needle on the business, or received a strategic plan filled with bright, but flawed and non-implementable ideas.

We’ve held many roles - executives, entrepreneurs, and consultants. These experiences mean we have seen numerous scenarios from multiple viewpoints. You will never have to question our loyalty. When you partner with us, it’s your agenda, period.

If all this resonates with you, then we are

... on your Wavelength

Global News in Lifesciences, Healthcare, and Technology

ControlRad(R) Announces FDA Clearance for ControlRad Select

ATLANTA, March 4, 2021 -- (Healthcare Sales & Marketing Network) -- ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, has announced the ...
Devices, Interventional, FDA, Distribution
ControlRad, ControlRad Select, Boston Scientific, fluoroscopy

Comcast xFi Advanced Gateway Modem/Router

Here is Comcast?s most advanced modem/router which promises speed as well as ease of use.

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 -- (Healthcare Sales & Marketing Network) -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DE...
Devices, Interventional, Cardiology, FDA
MedAlliance, SELUTION SLR, Sirolimus, Drug Eluting Balloon

Harman Kardon ? Home Speaker with Cortana

Here is a premium home speaker with superior sound coupled with Microsoft?s Cortana